The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Sunovion Pharmaceuticals Europe LtdEU/1/14/913/008-014

Main Information

Trade NameLatuda
Active SubstancesLurasidone hydrochloride
Dosage FormFilm-coated tablet
Licence HolderSunovion Pharmaceuticals Europe Ltd
Licence NumberEU/1/14/913/008-014

Group Information

ATC CodeN05AE Indole derivatives
N05AE05 lurasidone


License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription. (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back